Skip to main content
Top
Published in: International Journal of Clinical Pharmacy 3/2018

01-06-2018 | Research Article

Patients’ perspective of the impact of COPD on quality of life: a focus group study for patients with COPD

Authors: Anan Jarab, Eman Alefishat, Tareq Mukattash, Karem Alzoubi, Sharrel Pinto

Published in: International Journal of Clinical Pharmacy | Issue 3/2018

Login to get access

Abstract

Background The quality of life has been shown to be poor in patients with chronic obstructive pulmonary disease (COPD). Furthermore, patients’ perspective and attitudes toward COPD and its impact on their quality of life have been remarkably ignored. Objective To explore patients’ views and perceptions regarding COPD and its impact on their quality of life. Setting COPD clinic at the Royal Medical Services Hospital, Amman, Jordan. Method Focus groups discussions to explore patients’ views and perceptions about COPD were conducted using purposive sampling technique till data saturation achieved. A predesigned topic guides including knowledge about COPD and its management and the impact of COPD on the quality of life in patients with COPD was used to facilitate discussion during the interviews. All interviews were transcribed and analyzed using a thematic analysis approach. Main outcome measure Impact of COPD on patients’ quality of life. Results The main themes emerged included information needs about COPD and its management, physical and psychological impact of COPD and reliance on others. The most commonly expressed problem was breathlessness which restricted physical activity and led to panic and anxiety attacks. Constant breathlessness coupled with anxiety can force COPD patient to avoid all physical activity and becoming reliant on others. Conclusion In addition to the lack of knowledge about COPD and its management, it was evident that COPD had a negative physical and psychological impact on COPD patients. Future disease management and clinical pharmacy services programs should address the current study findings in order to improve the health outcomes for patients with COPD.
Literature
2.
go back to reference Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S. The GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.CrossRefPubMed Pauwels R, Buist A, Calverley P, Jenkins C, Hurd S. The GOLD Scientific Committee. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease. NHLBI/WHO global initiative for chronic obstructive lung disease (GOLD) workshop summary. Am J Respir Crit Care Med. 2001;163(5):1256–76.CrossRefPubMed
4.
go back to reference Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMed Vestbo J, Hurd SS, Agustí AG, Jones PW, Vogelmeier C, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med. 2013;187(4):347–65.CrossRefPubMed
5.
go back to reference McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793. McCarthy B, Casey D, Devane D, Murphy K, Murphy E, Lacasse Y. Pulmonary rehabilitation for chronic obstructive pulmonary disease. Cochrane Database Syst Rev. 2015;2:CD003793.
6.
go back to reference Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed Lozano R, Naghavi M, Foreman K, Lim S, Shibuya K, Aboyans V, et al. Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010. Lancet. 2012;380(9859):2095–128.CrossRefPubMed
7.
go back to reference Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRefPubMed Mannino DM, Buist AS. Global burden of COPD: risk factors, prevalence, and future trends. Lancet. 2007;370(9589):765–73.CrossRefPubMed
8.
go back to reference Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412.CrossRefPubMed Lopez AD, Shibuya K, Rao C, Mathers CD, Hansell AL, Held LS, et al. Chronic obstructive pulmonary disease: current burden and future projections. Eur Respir J. 2006;27(2):397–412.CrossRefPubMed
9.
go back to reference Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–91.CrossRefPubMed Murray CJ, Barber RM, Foreman KJ, Abbasoglu Ozgoren A, Abd-Allah F, Abera SF, et al. Global, regional, and national disability-adjusted life years (DALYs) for 306 diseases and injuries and healthy life expectancy (HALE) for 188 countries, 1990–2013: quantifying the epidemiological transition. Lancet. 2015;386(10009):2145–91.CrossRefPubMed
10.
go back to reference Wong SS, Abdullah N, Abdullah A, Liew SM, Ching SM, Khoo EM, et al. Unmet needs of patients with chronic obstructive pulmonary disease (COPD): a qualitative study on patients and doctors. BMC Fam Pract. 2014;15:67.CrossRefPubMedPubMedCentral Wong SS, Abdullah N, Abdullah A, Liew SM, Ching SM, Khoo EM, et al. Unmet needs of patients with chronic obstructive pulmonary disease (COPD): a qualitative study on patients and doctors. BMC Fam Pract. 2014;15:67.CrossRefPubMedPubMedCentral
11.
go back to reference Belbeisi A, Al Nsour M, Batieha A, Brown DW, Walke HT. A surveil-lance summary of smoking and review of tobacco control in Jordan. Global Health. 2009;5:18.CrossRefPubMedPubMedCentral Belbeisi A, Al Nsour M, Batieha A, Brown DW, Walke HT. A surveil-lance summary of smoking and review of tobacco control in Jordan. Global Health. 2009;5:18.CrossRefPubMedPubMedCentral
12.
go back to reference Al Omari M, Khassawneh BY, Khader Y, Dauod AS, Bergus G. Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan. Int J Chron Obstruct Pulmon Dis. 2014;9:753–8.PubMedPubMedCentral Al Omari M, Khassawneh BY, Khader Y, Dauod AS, Bergus G. Prevalence of chronic obstructive pulmonary disease among adult male cigarettes smokers: a community-based study in Jordan. Int J Chron Obstruct Pulmon Dis. 2014;9:753–8.PubMedPubMedCentral
13.
go back to reference Tageldin MA, Nafti S, Khan JA, Nejjari C, Beji M, Mahboub B, et al. Dis-tribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106(Suppl 2):S25–32.CrossRefPubMed Tageldin MA, Nafti S, Khan JA, Nejjari C, Beji M, Mahboub B, et al. Dis-tribution of COPD-related symptoms in the Middle East and North Africa: results of the BREATHE study. Respir Med. 2012;106(Suppl 2):S25–32.CrossRefPubMed
15.
go back to reference Kitzinger J. The methodology of focus groups: the importance of interaction between research participants. Sociol Health. 1994;16(1):103–21.CrossRef Kitzinger J. The methodology of focus groups: the importance of interaction between research participants. Sociol Health. 1994;16(1):103–21.CrossRef
16.
go back to reference Chang MY, Hsu LL. Qualitative research: an introduction to focus group methodology and its application. J Nurs. 2006;53(2):67–72. Chang MY, Hsu LL. Qualitative research: an introduction to focus group methodology and its application. J Nurs. 2006;53(2):67–72.
18.
go back to reference Glaser BD, Strauss AL. The discovery of grounded theory: strategies for qualitative research. New York: Aldine; 1967. Glaser BD, Strauss AL. The discovery of grounded theory: strategies for qualitative research. New York: Aldine; 1967.
19.
go back to reference Lennon C, Hughes C, Johnston D, McElnay J. Identification of psychosocial factors which influence patient adherence with antihypertensive medication. IJPP. 2001;9:113–4. Lennon C, Hughes C, Johnston D, McElnay J. Identification of psychosocial factors which influence patient adherence with antihypertensive medication. IJPP. 2001;9:113–4.
21.
go back to reference Sheridan N, Kenealy T, Salmon E, Rea H, Raphael D, Schmidt-Busby J. Helplessness, self-blame and faith may impact on self-management in COPD: a qualitative study. Prim Care Respir J. 2011;20(3):307–14.CrossRefPubMed Sheridan N, Kenealy T, Salmon E, Rea H, Raphael D, Schmidt-Busby J. Helplessness, self-blame and faith may impact on self-management in COPD: a qualitative study. Prim Care Respir J. 2011;20(3):307–14.CrossRefPubMed
22.
go back to reference Nakken N, Janssen DJA, van den Bogaart EHA, Muris JWM, Vercoulen JH, Custers FL, et al. Knowledge gaps in patients with COPD and their proxies. BMC Pulm Med. 2017;17(1):136.CrossRefPubMedPubMedCentral Nakken N, Janssen DJA, van den Bogaart EHA, Muris JWM, Vercoulen JH, Custers FL, et al. Knowledge gaps in patients with COPD and their proxies. BMC Pulm Med. 2017;17(1):136.CrossRefPubMedPubMedCentral
23.
go back to reference Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003;65(6):963–70.CrossRefPubMed Brenes GA. Anxiety and chronic obstructive pulmonary disease: prevalence, impact, and treatment. Psychosom Med. 2003;65(6):963–70.CrossRefPubMed
24.
go back to reference Schroedl CJ, Yount SE, Szmuilowicz E, Hutchison PJ, Rosenberg SR, Kalhan R. A qualitative study of unmet healthcare needs in chronic obstructive pulmonary disease. A potential role for specialist palliative care? Ann Am Thorac Soc. 2014;11(9):1433–8.CrossRefPubMedPubMedCentral Schroedl CJ, Yount SE, Szmuilowicz E, Hutchison PJ, Rosenberg SR, Kalhan R. A qualitative study of unmet healthcare needs in chronic obstructive pulmonary disease. A potential role for specialist palliative care? Ann Am Thorac Soc. 2014;11(9):1433–8.CrossRefPubMedPubMedCentral
25.
go back to reference Paap MC, Bode C, Lenferink LI, Groen LC, Terwee CB, Ahmed S, et al. Identifying key domains of healthrelated quality of life for patients with chronic obstructivepulmonary disease: the patient perspective. Health Qual Life Outcomes. 2014;12:106.CrossRefPubMedPubMedCentral Paap MC, Bode C, Lenferink LI, Groen LC, Terwee CB, Ahmed S, et al. Identifying key domains of healthrelated quality of life for patients with chronic obstructivepulmonary disease: the patient perspective. Health Qual Life Outcomes. 2014;12:106.CrossRefPubMedPubMedCentral
26.
go back to reference Svedsater H, Roberts J, Patel C, Macey J, Hilton E, Bradshaw L. Life impact and treatment preferences of individuals with asthma and chronicobstructive pulmonary disease: results from qualitative interviews and focus groups. Adv Ther. 2017;34(6):1466–81.CrossRefPubMedPubMedCentral Svedsater H, Roberts J, Patel C, Macey J, Hilton E, Bradshaw L. Life impact and treatment preferences of individuals with asthma and chronicobstructive pulmonary disease: results from qualitative interviews and focus groups. Adv Ther. 2017;34(6):1466–81.CrossRefPubMedPubMedCentral
27.
go back to reference Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–74.CrossRefPubMed Di Marco F, Verga M, Reggente M, Maria Casanova F, Santus P, Blasi F, et al. Anxiety and depression in COPD patients: the roles of gender and disease severity. Respir Med. 2006;100(10):1767–74.CrossRefPubMed
28.
go back to reference Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease. Arch Intern Med. 2007;167(1):60–7.CrossRefPubMed Ng TP, Niti M, Tan WC, Cao Z, Ong KC, Eng P. Depressive symptoms and chronic obstructive pulmonary disease. Arch Intern Med. 2007;167(1):60–7.CrossRefPubMed
29.
go back to reference Cicutto L, Brooks D, Henderson K. Self-care issues from the perspective of individuals with chronic obstructive pulmonary disease. Patient Educ Couns. 2004;55(2):168–76.CrossRefPubMed Cicutto L, Brooks D, Henderson K. Self-care issues from the perspective of individuals with chronic obstructive pulmonary disease. Patient Educ Couns. 2004;55(2):168–76.CrossRefPubMed
30.
go back to reference Guthrie SJ, Hill KM, Muers ME. Living with severe COPD. A qualitative exploration of the experience of patients in Leeds. Respir Med. 2001;95(3):196–204.CrossRefPubMed Guthrie SJ, Hill KM, Muers ME. Living with severe COPD. A qualitative exploration of the experience of patients in Leeds. Respir Med. 2001;95(3):196–204.CrossRefPubMed
Metadata
Title
Patients’ perspective of the impact of COPD on quality of life: a focus group study for patients with COPD
Authors
Anan Jarab
Eman Alefishat
Tareq Mukattash
Karem Alzoubi
Sharrel Pinto
Publication date
01-06-2018
Publisher
Springer International Publishing
Published in
International Journal of Clinical Pharmacy / Issue 3/2018
Print ISSN: 2210-7703
Electronic ISSN: 2210-7711
DOI
https://doi.org/10.1007/s11096-018-0614-z

Other articles of this Issue 3/2018

International Journal of Clinical Pharmacy 3/2018 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.